A first in human study of cannabis-based therapies for the treatment of early to moderate Parkinson's disease ("PD").

Trial Profile

A first in human study of cannabis-based therapies for the treatment of early to moderate Parkinson's disease ("PD").

Planning
Phase of Trial: Phase 0

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs Marijuana
  • Indications Parkinson's disease
  • Focus Adverse reactions; First in man
  • Sponsors GB Sciences
  • Most Recent Events

    • 12 Apr 2018 New trial record
    • 10 Apr 2018 According to a GB Sciences media release, company is planning to file an Exploratory IND application to the US FDA. This study is expected to start in early 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top